Subsidiaries
UBM
If this is your company, CONTACT US to activate Packbase™ software to build your portal.
Pharma prepares for CDMO growth in 2025 as CPHI Milan reports record attendance- Saudi Arabia Poised to Expand Domestic Manufacturing Eco-system as 30,000 Attendees join Inaugural CPHI Middle East
- CPHI Milan Report: CMOs and hybrid companies will hold 54% of biologics capacity in 2028
- CPHI Milan Survey ‘faster CDMO growth in 2025 predicted’ and ‘industry not in favour of BIOSECURE Act’
- Biotech Capital on the Rise and Outsourcing to Accelerate in 2025 - but Uneven Growth for CDMOs
- CPHI Excellence in Pharma Award Winners 2024
- Global Sustainability Collective and Women’s Mentoring Programme announced at CPHI Milan
- CPHI Milan analysis ‘Lombardy the best location for pharma manufacturing in Europe’
- CPHI Milan Report predicts BLA and Tides approvals will surpass small molecules within the next three years
- CPHI Milan Announce Pharma Award finalists
- CPHI Korea 2024 opens with 15% growth as innovation booms in Korea
- Pharma services boom in China as CPHI & PMEC China posts record attendance
- Dive into the Heart of Pharma at CPHI Milan, October 8-10th 2024 – a celebration of pharma
- Dive into the Heart of Pharma at CPHI Milan, October 8-10th 2024 – a celebration of pharma
- CPHI South East Asia opens as growth prospects outlined for pharmaceutical development in Vietnam, Thailand and Cambodia
- CPHI returns to the Messe Frankfurt in 2025
- CPHI North America expanding Bioproduction focus for 2025
- Record numbers expected at CPHI & PMEC China 2024 as Asian markets boom
- CPHI North America experts ‘mid-sized domestic CDMOs need to invest in operational efficiencies to drive “real” reshoring’
- Rapid increase in purchasing teams expected at CPHI North America
- CPHI North America opens as 65% of US companies forecast growth in excess of 20% in 2022
- Japan tops CPhI ‘API Quality’ ranking for second year
- 2022 will see pharma target nutraceutical products to tap into consumer spending on preventative health
- CPhI predictions for 2022: high manufacturing demand to constrain global ingredients, partnering options and available CDMO capacity
- Medinfar awarded first ever CPhI Verified Certificate
- Global pharma industry gathers at CPhI Worldwide 2021 as surge in partnering expected in 2022
- China sees huge bounce in pharma rankings ahead of hybrid CPhI & P-MEC China
- Pharma confidence surges as CPhI Worldwide 2021 opens
- Winners of the 2021 CPhI Pharma Awards have now been announced
- CPhI Worldwide Report: CMOs will account for four of the five top bio manufacturing capacities in 2025
- India sees sizable improvement in finished dosage reputation and growth ahead of CPhI India 2021
- Short term reshoring the catalyst for longer term manufacturing innovations by 2030
- CPhI Worldwide Fiera Milano: Uniting The Industry To Network & Source Cost-Effective Solutions
- CPhI Report predicts record EBITDAs for CDMOs in 2022
- CPhI partners with SGS for Company Verification Service
- CPhI Awards 2021 Open for Entries in Incredible Year for Pharma Innovation
- CPhI report predicts ‘supercharged partnering’ in USA Pharma sector over the next 18-months
- Pharma accelerating new partnership development at CPhI Discover ahead of returning in-person events
- Experts state contract services sector the big winner of pandemic at CPhI Discover
- CPhI Japan celebrates return, as cell & gene therapies and digital innovation highlighted
- CPhI post-pandemic executive pharma survey: COVID-19 driving manufacturing and CDMOs driving growth
- CPhI post-pandemic executive pharma survey: COVID-19 driving manufacturing and CDMOs driving growth
- CPhI Discover: event overview and highlights
- CPhI Discover: connecting global pharma & pre-qualifying partners ahead of in person events
- Two-month long CPhI Japan Connect to meet demand for pharma partnering in Japan
- CPhI Report forecasts explosion of contract services growth due to surging INDs and 75 FDA approvals by 2025
- CPhI Worldwide Announces New November 2021 Dates
- CPhI & P-MEC China gives a glimpse of the success returning pharma events will deliver in 2021
- Vaccine nationalism, CDMO expansion, AMR and dual sourcing predicted in 2021 according to CPhI Report
- CPhI & P-MEC China 2020 adapts to customer needs with hybrid pharma event
- CDMOs benefit from COVID-19 impacts but mega-cap pharma innovation slowing outsourcing according to CPhI Annual Report
- CPhI Worldwide to return in 2021: Milan venue to play host to global pharma as Italy gears up for strong growth
- Approvals of COVID-19 biologics will put huge pressure on large-scale bioprocessing networks, according to CPhI Annual Report
- CPhI Announces 17th Annual CPhI Pharma Awards Winners
- CPhI Annual Report 2020 Part 1: 2025 will see cell and gene therapy capacity shortages in the USA and 10+ mAb approvals in China
- Full CPhI & Pharmapack Europe schedule returns in 2021 with live & hybrid events
- CPhI Festival of Pharma: event overview and highlights
- CPhI Pharma Index: Italy and India the only pharma economies to improve score in 2020
- CPhI Middle East & Africa to take place in September 2021 under the patronage of Saudi Arabia’s Ministry of Health
- World’s Largest Virtual Pharma Expo Agenda Unveiled: Former FDA Commissioner Dr. Scott Gottlieb to address industry on sustainable innovation at CPhI Festival of Pharma
- CPhI South East Asia rescheduled for 2021
- CPhI Japan rescheduled for Spring 2021 with digital solutions to be launched
- CPhI Festival of Pharma to support and lead global pharma industry forward with new digital experience in 2020
- CPhI Middle East & Africa cancelled for 2020 but set to debut in Saudi Arabia in 2021
- CPhI Worldwide 2020 implements new ‘Informa AllSecure Standard’
- CPhI & P-MEC China to host ‘Virtual Expo Connect’ in June
- Rescheduled CPhI South East Asia to now take place in November
- CPhI & P-MEC China moves to December date to enable international attendance
- 2020 CPhI Pharma Awards are Open for Entries
- CPhI announces new pharma events calendar for 2020
- CPhI Japan to be postponed on request of event attendees
- CPhI South East Asia rescheduled for July 2020
- CPhI Southeast Asia Report: executives call for track-and-trace schemes in Southeast Asia
- CPhI Worldwide announces the winners of the 16th Pharma Awards
- CPhI Pharmaceutical Machinery Report: Critical time to invest in machinery with changing drugs pipeline
- Drive for generics sees Korea increasingly attractive to international pharma
- Huge CPhI & P-MEC China a direct result of surging manufacturing
- CPhI Worldwide opens entries for the CPhI Pharma Awards 2019
- CPhI Japan sees Japanese R&D reinvigorated with international partnerships proliferating
.jpg)
